THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis
Europe - FRA:TN8 - US8835561023 - Common Stock
455.5 EUR
+1.85 (+0.41%)
We assign a fundamental rating of 5 out of 10 to TN8. TN8 was compared to 20 industry peers in the Life Sciences Tools & Services industry. TN8 scores excellent on profitability, but there are some minor concerns on its financial health. TN8 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
TN8 had positive earnings in the past year.
TN8 had a positive operating cash flow in the past year.
Each year in the past 5 years TN8 has been profitable.
TN8 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of TN8 (6.50%) is better than 90.00% of its industry peers.
TN8 has a Return On Equity of 13.04%. This is amongst the best in the industry. TN8 outperforms 85.00% of its industry peers.
The Return On Invested Capital of TN8 (6.25%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for TN8 is in line with the industry average of 7.27%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROIC | 6.25% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
1.3 Margins
TN8's Profit Margin of 15.24% is amongst the best of the industry. TN8 outperforms 90.00% of its industry peers.
TN8's Profit Margin has been stable in the last couple of years.
TN8 has a Operating Margin of 18.18%. This is in the better half of the industry: TN8 outperforms 70.00% of its industry peers.
TN8's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.34%, TN8 is in line with its industry, outperforming 60.00% of the companies in the same industry.
TN8's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% |
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TN8 is destroying value.
The number of shares outstanding for TN8 has been reduced compared to 1 year ago.
TN8 has less shares outstanding than it did 5 years ago.
TN8 has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of TN8 is 5.71, which is a neutral value as it means it would take TN8, 5.71 years of fcf income to pay off all of its debts.
TN8 has a Debt to FCF ratio of 5.71. This is comparable to the rest of the industry: TN8 outperforms 55.00% of its industry peers.
TN8 has a Debt/Equity ratio of 0.65. This is a neutral value indicating TN8 is somewhat dependend on debt financing.
TN8 has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: TN8 outperforms 55.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Altman-Z | N/A |
ROIC/WACC0.62
WACC10.14%
2.3 Liquidity
A Current Ratio of 1.93 indicates that TN8 should not have too much problems paying its short term obligations.
TN8 has a better Current ratio (1.93) than 95.00% of its industry peers.
TN8 has a Quick Ratio of 1.50. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
TN8 has a Quick ratio of 1.50. This is amongst the best in the industry. TN8 outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.23% over the past year.
Measured over the past years, TN8 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.12% on average per year.
The Revenue has been growing slightly by 2.05% in the past year.
Measured over the past years, TN8 shows a quite strong growth in Revenue. The Revenue has been growing by 10.92% on average per year.
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
3.2 Future
Based on estimates for the next years, TN8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.78% on average per year.
The Revenue is expected to grow by 4.62% on average over the next years.
EPS Next Y4.02%
EPS Next 2Y6.1%
EPS Next 3Y7.53%
EPS Next 5Y9.78%
Revenue Next Year2.76%
Revenue Next 2Y3.79%
Revenue Next 3Y4.46%
Revenue Next 5Y4.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 24.41 indicates a rather expensive valuation of TN8.
The rest of the industry has a similar Price/Earnings ratio as TN8.
When comparing the Price/Earnings ratio of TN8 to the average of the S&P500 Index (27.86), we can say TN8 is valued inline with the index average.
With a Price/Forward Earnings ratio of 21.72, TN8 is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as TN8.
When comparing the Price/Forward Earnings ratio of TN8 to the average of the S&P500 Index (23.32), we can say TN8 is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.41 | ||
| Fwd PE | 21.72 |
4.2 Price Multiples
TN8's Enterprise Value to EBITDA ratio is in line with the industry average.
TN8's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.71 | ||
| EV/EBITDA | 21.33 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TN8 may justify a higher PE ratio.
PEG (NY)6.07
PEG (5Y)2.01
EPS Next 2Y6.1%
EPS Next 3Y7.53%
5. Dividend
5.1 Amount
TN8 has a yearly dividend return of 0.33%, which is pretty low.
TN8's Dividend Yield is slightly below the industry average, which is at 0.71.
Compared to an average S&P500 Dividend Yield of 2.44, TN8's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
5.2 History
On average, the dividend of TN8 grows each year by 15.37%, which is quite nice.
Dividend Growth(5Y)15.37%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
TN8 pays out 9.26% of its income as dividend. This is a sustainable payout ratio.
The dividend of TN8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP9.26%
EPS Next 2Y6.1%
EPS Next 3Y7.53%
FRA:TN8 (10/3/2025, 7:00:00 PM)
455.5
+1.85 (+0.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.65%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap172.00B
Analysts81.76
Price Target483.4 (6.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
Yearly Dividend1.29
Dividend Growth(5Y)15.37%
DP9.26%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)0.72%
Min EPS beat(4)-0.34%
Max EPS beat(4)1.69%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)7
Avg EPS beat(12)1.2%
EPS beat(16)11
Avg EPS beat(16)5.31%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.28%
Max Revenue beat(2)0.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.62%
Revenue beat(8)5
Avg Revenue beat(8)-0.15%
Revenue beat(12)7
Avg Revenue beat(12)0.84%
Revenue beat(16)11
Avg Revenue beat(16)3.32%
PT rev (1m)0.34%
PT rev (3m)-1.86%
EPS NQ rev (1m)-0.08%
EPS NQ rev (3m)-0.42%
EPS NY rev (1m)0.04%
EPS NY rev (3m)0.85%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.41 | ||
| Fwd PE | 21.72 | ||
| P/S | 4.67 | ||
| P/FCF | 32.71 | ||
| P/OCF | 26.63 | ||
| P/B | 4 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.33 |
EPS(TTM)18.66
EY4.1%
EPS(NY)20.97
Fwd EY4.6%
FCF(TTM)13.93
FCFY3.06%
OCF(TTM)17.1
OCFY3.75%
SpS97.52
BVpS113.92
TBVpS-26.9
PEG (NY)6.07
PEG (5Y)2.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROCE | 8.88% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 28.04% | ||
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% | ||
| FCFM | 14.28% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Debt/EBITDA | 3.08 | ||
| Cap/Depr | 49.03% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 70.63% | ||
| Profit Quality | 93.71% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | N/A |
F-Score7
WACC10.14%
ROIC/WACC0.62
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
EPS Next Y4.02%
EPS Next 2Y6.1%
EPS Next 3Y7.53%
EPS Next 5Y9.78%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
Revenue Next Year2.76%
Revenue Next 2Y3.79%
Revenue Next 3Y4.46%
Revenue Next 5Y4.62%
EBIT growth 1Y5.17%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year13.53%
EBIT Next 3Y9.14%
EBIT Next 5Y8.68%
FCF growth 1Y5.4%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-1.49%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%